These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 31445586)
1. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411. Kidney Int; 2019 Sep; 96(3):796. PubMed ID: 31445586 [No Abstract] [Full Text] [Related]
2. Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice. Nuvolone M; Merlini G Kidney Int; 2019 Feb; 95(2):258-260. PubMed ID: 30665564 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715. Heybeli C; Bentall A; Wen J; Alexander MP; Buadi FK; Cosio FG; Dean PG; Dispenzieri A; Dingli D; El Ters M; Gertz MA; Amer H; Kapoor P; Khamash H; Kourelis T; Kumar S; Lorenz EC; Mai M; Muchtar E; Murray DL; Prieto M; Schinstock CA; Stegall MD; Warsame R; Leung N Kidney Int; 2021 Dec; 100(6):1348-1349. PubMed ID: 34802563 [No Abstract] [Full Text] [Related]
4. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173 [TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248 [TBL] [Abstract][Full Text] [Related]
7. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Sherif AM; Refaie AF; Sobh MA; Mohamed NA; Sheashaa HA; Ghoneim MA Am J Kidney Dis; 2003 Aug; 42(2):370-5. PubMed ID: 12900821 [TBL] [Abstract][Full Text] [Related]
9. [Heart transplantation and the subsequent treatment of AL amyloidosis]. Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404 [TBL] [Abstract][Full Text] [Related]
10. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972 [TBL] [Abstract][Full Text] [Related]